Drug Type Small molecule drug |
Synonyms FP30 |
Target |
Action inhibitors |
Mechanism EPHX2 inhibitors(Epoxide hydratase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | Turkey | 01 Oct 2025 | |
| Neuralgia | Preclinical | Turkey | 01 Oct 2025 |





